Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 6Terminated 4Unknown 2Recruiting 2Active not recruiting 2Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 140Thoracic 4Sarcoma 3Genitourinary 2Gastrointestinal 2Dermatologic 2CNS 2Other solid neoplasm 1Lymphoid 1Gynecologic 1Breast 1

Conditions

Prostatic Neoplasms 957Urinary Bladder Neoplasms 264Carcinoma, Renal Cell 251Kidney Neoplasms 147Carcinoma, Transitional Cell 129Breast Neoplasms 127Neoplasms 122Colorectal Neoplasms 97Ovarian Neoplasms 90Melanoma 85Carcinoma, Non-Small-Cell Lung 84Lung Neoplasms 81Neoplasm Metastasis 79Pancreatic Neoplasms 68Non-Muscle Invasive Bladder Neoplasms 68Uterine Cervical Neoplasms 58Stomach Neoplasms 55Head and Neck Neoplasms 51Squamous Cell Carcinoma of Head and Neck 47Endometrial Neoplasms 47Adenocarcinoma 45Esophageal Neoplasms 44Testicular Neoplasms 42Carcinoma, Hepatocellular 41Sarcoma 39Disease 33Triple Negative Breast Neoplasms 32Liver Neoplasms 30Colonic Neoplasms 29Metastatic Castration-resistant Prostate Cancer 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Nasopharyngeal Carcinoma × Genitourinary × Clear all
NCT07584499 2026-05-13

MRG003

Sun Yat-sen University

Phase 1 Recruiting
51 enrolled
CNSGenitourinaryHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Nasopharyngeal Carcinoma, Medulloblastoma, Neoplasm Metastasis, Wilms Tumor, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Rhabdoid Tumor

NCT06852638 2026-05-12

CD70-targeted immunoPET Imaging of Malignant Cancers

RenJi Hospital

Phase 2 Recruiting
300 enrolled
GenitourinaryHead & NeckLymphoid

Nasopharyngeal Carcinoma, Carcinoma, Renal Cell, Kidney Neoplasms, Lymphoma, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡